Actelion said on Tuesday that, by decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all its publicly held registered shares with a nominal value of CHF 0.50 each (the Actelion Shares).
The company said that the shareholders will be paid a cash compensation in the amount of $280 for each cancelled Actelion Share, corresponding to the offer price paid by Janssen Holding GmbH, an indirect subsidiary of Johnson & Johnson, in its public tender offer for all publicly held Actelion Shares. The settlement and payment of the compensation to the remaining minority shareholders of Actelion will take place on or around November 10, 2017.
By decision from April, 2017, SIX Exchange Regulation approved the delisting of the Actelion Shares from SIX Swiss Exchange. By decision dated October 30, 2017, SIX Exchange Regulation determined that the last day of trading of the Actelion Shares will be November 6, 2017 and that the Actelion Shares will be delisted from SIX Swiss Exchange on November 7, 2017.